Merge Talks Between The EVERY Co and Onego Bio
Alt-egg startups The EVERY Company and Onego Bio were discussing a merger before talks fell apart, leading to Onego suing its rival, according to court documents.
The EVERY Co has urged a court in Wisconsin to dismiss a lawsuit from Onego Bio seeking to invalidate one of EVERY's patents, which covers the production of ovalbumin via precision fermentation.
- The EVERY Co uses yeast (Komagataella phaffii) as its host microorganism.
- Onego Bio uses fungus (Trichoderma reesei).
A court filing disclosed the valuation figure, but the company has since asked the court to seal that information.
No specific quotes are available in the given text.
Author's summary: Merger talks between The EVERY Co and Onego Bio failed.
More News
- How 'hydroclimate whiplash' and climate change may have contributed to severity of LA fires
- Selah Freedom Invites Community To ‘Unmasked’ Gala To Support Survivors Of Sex Trafficking
- Trump Administration Admits It Doesn’t Know Who Exactly It’s Killing in Boat Strikes
- Jerry Jones needs to learn from Carlie Irsay-Gordon if he wants the Cowboys to win the Super Bowl
- Canva’s Affinity Combines Photo, Designer, and Publisher into One Free App - TidBITS
- Can Joji, Tame Impala or Chris Brown & Usher Make Waves on the Hot 100 Next Week? | The Contenders